Clinical Trials Logo

Clinical Trial Summary

Primary objective of the trial:

To determine at which concentration the fusion protein MAT Fel d1 degranulates basophils of cat dander allergic patients, in comparison to a cat dander extract and to Fel d1 alone


Clinical Trial Description

n/a


Study Design

Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT00620880
Study type Observational
Source University of Zurich
Contact
Status Completed
Phase N/A
Start date September 2005
Completion date September 2006

See also
  Status Clinical Trial Phase
Completed NCT05455749 - Effect of holoBLG on Cat Allergic Patients N/A
Active, not recruiting NCT04619017 - Airway Immune Response to Allergens (Use Lay Language Here) Phase 1
Withdrawn NCT04401631 - Analytical Validation of the abioSCOPE Device With an IgE Test Panel: Point-of-Care Precision, Sample Type Comparison and Method Correlation
Withdrawn NCT04442932 - abioSCOPE IgE Assay to Aid in the Diagnosis of Allergies
Not yet recruiting NCT06069063 - Crossover Study of Zafirlukast in Preventing Allergen-induced Signs and Symptoms in Response to Cat Dander Challenge Phase 2
Completed NCT04678063 - Validation of Strasbourg Environmental Exposure Chamber ALYATEC in Cat Allergic Subjects With Asthma N/A